Declares that the purpose of this act is to provide for the adoption of minimum standards related to pharmaceutical manufacturer marketing activities within the state of Washington.

Provides that, beginning January 1, 2010, and annually thereafter, every pharmaceutical manufacturer shall submit an attestation with a written report documenting that the manufacturer, for purposes of its operations in the state of Washington, has: (1) Adopted a comprehensive compliance program that is at least as stringent as the April 2003 publication "compliance program guidance for pharmaceutical manufacturers";

(2) Included in its comprehensive compliance program policies that are at least as stringent as the pharmaceutical research and manufacturers of America "code on interactions with health care professionals," dated July 1, 2002; and

(3) Included in its comprehensive compliance program limits on gifts or incentives provided to medical or health professionals, in accordance with this act.